Abstract
Objective:To investigate the safety and tolerability of high-dose cyclophosphamide without stem cell rescue in scleroderma.Methods:An open-label, single-site, uncontrolled study design entered patients with active diffuse cutaneous scleroderma. Patients were treated...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
